Suven Pharma

Hyderabad, India Founded: 1989 • Age: 37 yrs Acquired By Advent International
Contract manufacturing and development of APIs and formulations are provided.
Request Access

About Suven Pharma

Suven Pharma is a company based in Hyderabad (India) founded in 1989 was acquired by Advent International in December 2022. It operates as a Professional Services. The company has 2,290 employees as of March 31, 2024. Suven Pharma has completed 3 acquisitions, including Casper Pharma, NJ Bio and Sapala Organics. Suven Pharma offers products and services including Formulation Development and Analytical Services, Process Research, Custom Synthesis, and Clinical Supplies Manufacturing & Packaging. Suven Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

  • Headquarter Hyderabad, India
  • Employees 2290 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Cohance Lifesciences Ltd
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $137.85 M (USD)
    13.94
    as on Mar 31, 2024
  • Net Profit
    $31.31 M (USD)
    -10.79
    as on Mar 31, 2024
  • EBITDA
    $46.61 M (USD)
    -1.34
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    2290

    as on Mar 31, 2024

  • Investments & Acquisitions
  • Acquired by
    Advent International

    (Dec 26, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Suven Pharma

Suven Pharma is a publicly listed company on the NSE with ticker symbol COHANCE in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: COHANCE . Sector: Health technology · India

Products & Services of Suven Pharma

Suven Pharma offers a comprehensive portfolio of products and services, including Formulation Development and Analytical Services, Process Research, Custom Synthesis, and Clinical Supplies Manufacturing & Packaging. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Services for formulation and analytical development are provided.

Efficient and cost-effective drug production is ensured here.

Novel molecules are accessed for cost-effective drug production.

Clinical trial supplies are delivered meeting regulatory requirements.

People of Suven Pharma
Headcount 1000-5000
Employee Profiles 4
Employee Profiles
People
Srinivasu Metlapalli
Vice President EHS & ESG
People
Dr. Prasada Raju. V
Managing Director
People
Gaurav Bahadur
Chief Human Resources Officer
People
Himanshu Agarwal
Chief Financial Officer

Unlock access to complete

Funding Insights of Suven Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Suven Pharma

Suven Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advent International. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity firm focused on multiple sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Suven Pharma

Suven Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Casper Pharma, NJ Bio and Sapala Organics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Clinical development services are provided for biotechnology applications.
2018
Specialty pharmaceuticals in key therapeutic areas are developed and commercialized.
2016
Research organization specializing in custom synthesis of various organic compounds
2005
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Suven Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Suven Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Suven Pharma

Suven Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Integrated CDMO services for biopharma R&D and manufacturing are offered.
domain founded_year HQ Location
APIs manufacturing and formulation services are provided in therapeutic segments.
domain founded_year HQ Location
APIs and enzymes are manufactured through fermentation by the CDMO.
domain founded_year HQ Location
APIs and finished products are developed and manufactured.
domain founded_year HQ Location
Generic biocatalytic solutions are provided for pharmaceutical applications.
domain founded_year HQ Location
APIs and peptides are developed and manufactured by Asymchem.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Suven Pharma

Frequently Asked Questions about Suven Pharma

When was Suven Pharma founded?

Suven Pharma was founded in 1989.

Where is Suven Pharma located?

Suven Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Who is the current CEO of Suven Pharma?

Venkateswarlu Jasti is the current CEO of Suven Pharma.

How many employees does Suven Pharma have?

As of Mar 31, 2024, the latest employee count at Suven Pharma is 2,290.

What is the annual revenue of Suven Pharma?

Annual revenue of Suven Pharma is $137.85M as on Mar 31, 2024.

What does Suven Pharma do?

Suven Pharma is involved in providing contract development and manufacturing services for global pharmaceutical companies. The company focuses on formulation development, analytical services, process research, custom synthesis, and clinical supplies manufacturing. Operations are centered around supporting healthcare customers from lab to commercialization, with an emphasis on new chemical entities and fine chemical intermediates. Facilities and expertise are utilized to ensure efficient, safe, and cost-effective production across various pharmaceutical segments.

Who are the top competitors of Suven Pharma?

Suven Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

What products or services does Suven Pharma offer?

Suven Pharma offers Formulation Development and Analytical Services, Process Research, Custom Synthesis, and Clinical Supplies Manufacturing & Packaging.

Is Suven Pharma publicly traded?

Yes, Suven Pharma is publicly traded on NSE under the ticker symbol COHANCE.

How many acquisitions has Suven Pharma made?

Suven Pharma has made 3 acquisitions, including Casper Pharma, NJ Bio, and Sapala Organics.

Who are Suven Pharma's investors?

Suven Pharma has 1 investor. Key investors include Advent International.

What is Suven Pharma's ticker symbol?

The ticker symbol of Suven Pharma is COHANCE on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available